Actos (Pioglitazone) Cost in Colorado: 2026 Pricing, Insurance, and Savings Guide

What Does Pioglitazone Actually Cost in Colorado in 2026?

Generic pioglitazone averages $15 per month across Colorado retail pharmacies for a 30-day supply of once-daily tablets. Brand-name Actos carries a manufacturer list price of $60 per month from Takeda, though almost no pharmacy dispenses the brand when the generic is available at a fraction of the cost.

Retail Pharmacy Pricing Across CO

Prices vary by chain. Costco and Walmart pharmacies in Denver, Colorado Springs, and Fort Collins frequently list pioglitazone 30 mg at $4 to $8 for a 30-day supply through their in-house discount programs. King Soopers (Kroger) and Safeway locations typically charge $10 to $18 without a coupon. Independent pharmacies may charge $12 to $25 depending on their wholesaler contract.

Why the Generic Is So Cheap

Actos lost U.S. Patent exclusivity in August 2012. More than a decade of generic competition has pushed per-tablet costs below $0.50 in most markets. The FDA Orange Book lists over 10 approved ANDA holders for pioglitazone tablets, and Colorado's generic substitution law (C.R.S. § 12-280-120) requires pharmacists to dispense the generic unless the prescriber writes "brand medically necessary" [1].

Cash-Pay vs. Insurance Copay

For patients paying cash, the $15 average is often cheaper than a commercial insurance copay. Many Colorado plans set tier-1 generics at a $10 copay, but some high-deductible health plans (HDHPs) require patients to meet a $1,600+ individual deductible before any drug benefit applies. In those cases, a GoodRx or RxSaver coupon pulling the price to $4 to $8 may outperform insurance.

Colorado Medicaid and Pioglitazone Coverage

Colorado's Health First Colorado (Medicaid) program covers generic pioglitazone on its preferred drug list for the treatment of type 2 diabetes mellitus. No prior authorization is required for the 15 mg or 30 mg strengths when prescribed for FDA-approved indications.

What Medicaid Will Not Cover

Off-label use of pioglitazone for nonalcoholic steatohepatitis (NASH/MASH) is not covered under Colorado Medicaid as of 2026. The PIVENS trial (N=247) demonstrated that pioglitazone 30 mg improved histological features of NASH in non-diabetic patients compared to placebo over 96 weeks, with 34% of pioglitazone-treated patients achieving resolution of steatohepatitis versus 19% on placebo [2]. Despite this evidence, the American Association for the Study of Liver Diseases (AASLD) limits its recommendation to patients with biopsy-confirmed NASH, and most state Medicaid programs, Colorado included, have not added NASH as a covered indication.

Prior Authorization Exceptions

The 45 mg strength may require a prior authorization step. Colorado Medicaid formulary documents indicate that doses above 30 mg trigger a clinical review to confirm that the patient has not achieved adequate glycemic control on lower doses or on metformin combination therapy. Approval turnaround is typically 24 to 72 hours.

Commercial Insurance Coverage in Colorado

Most major Colorado insurers cover generic pioglitazone at tier 1. Anthem Blue Cross Blue Shield of Colorado, UnitedHealthcare, Cigna, Aetna, Kaiser Permanente Colorado, and Friday Health Plans all list pioglitazone on their 2026 formularies without prior authorization for type 2 diabetes.

Tier Placement and Cost Sharing

Tier-1 generic copays across these plans range from $0 (Kaiser Permanente CO select HMO) to $15 (Anthem Bronze HDHP after deductible). The 2025 Kaiser Family Foundation Employer Health Benefits Survey reported that the average tier-1 copay nationally was $11 [3]. Colorado tracks close to that average.

Brand-Name Actos Under Insurance

If a prescriber requests brand-name Actos via a "dispense as written" order, most plans reclassify it to tier 3 (preferred brand) with a $40 to $75 copay. A step-therapy requirement may also apply, meaning the plan will require documented failure of generic pioglitazone before approving brand coverage. For nearly all patients, the generic is clinically identical and dramatically cheaper.

HSA and FSA Eligibility

Pioglitazone purchased with a valid prescription qualifies as an eligible expense under Health Savings Accounts (HSAs) and Flexible Spending Accounts (FSAs). Patients on HDHPs in Colorado can use pre-tax HSA dollars to pay the $4 to $15 cash price, effectively reducing out-of-pocket cost by their marginal tax rate.

Discount Programs and Savings Cards in Colorado

Several pathways can bring pioglitazone costs below the $15 retail average.

Pharmacy Discount Programs

Walmart's $4 Generics List includes pioglitazone 15 mg and 30 mg for a 30-day supply. Costco's member pharmacy pricing runs $5 to $7 for the same quantities (no Costco membership required to use the pharmacy in Colorado per state law). Mark Cuban's Cost Plus Drugs lists pioglitazone 30 mg #30 at $4.20 plus a $5 shipping fee for mail-order delivery to Colorado addresses.

Manufacturer Savings and Patient Assistance

Takeda's patient assistance program (TAP) covers brand-name Actos for uninsured patients with household income below 250% of the federal poverty level. At $60 per month list price, the brand is rarely prescribed, so this program sees limited use. No manufacturer coupon exists specifically for generic pioglitazone because the price is already low enough that coupon programs would operate at a loss.

GoodRx, RxSaver, and SingleCare Coupons

These free coupon aggregators negotiate rates with pharmacy benefit managers. In the Denver metro area as of May 2026, GoodRx shows pioglitazone 30 mg #30 at $3.80 (Costco), $4.00 (Walmart), and $7.12 (Walgreens). Prices update frequently. Patients should compare at least three pharmacies before filling.

Compounded Pioglitazone in Colorado

Compounded pioglitazone is legal in Colorado through licensed 503A compounding pharmacies. Under section 503A of the Federal Food, Drug, and Cosmetic Act, a pharmacy may compound pioglitazone from bulk API powder pursuant to an individual patient prescription [4].

When Compounding Makes Sense

Given that generic pioglitazone tablets already cost $4 to $15, compounding is rarely cost-justified. The primary use case is a patient who requires a non-standard dose (e.g., 7.5 mg for NASH titration) or who cannot swallow tablets and needs a liquid suspension. Colorado 503A pharmacies such as Belmar Pharmacy (Lakewood) and Colorado Compounding Pharmacy (Colorado Springs) can fill these prescriptions.

Compounding Costs

Compounded pioglitazone may run $0 to $25 per month depending on the pharmacy's markup, the dose, and the formulation complexity. Some compounding pharmacies absorb the cost entirely when pioglitazone is combined with other compounded agents in a single preparation, effectively pricing the pioglitazone component at $0.

503B Outsourcing Facilities

Colorado also permits 503B outsourcing facilities to produce compounded pioglitazone without individual prescriptions for office use. This pathway is more relevant for clinical research settings or physician offices stocking non-standard doses. The FDA's 503B registration list tracks compliant facilities nationally.

Telehealth Access to Pioglitazone in Colorado

Colorado permits telehealth prescribing of pioglitazone with no in-person visit requirement for established or new patients. The Colorado Medical Board recognizes audio-video telehealth encounters as sufficient to establish a provider-patient relationship and prescribe scheduled and non-scheduled medications.

How Telehealth Prescribing Works

A Colorado-licensed prescriber (MD, DO, NP, or PA) evaluates the patient via a synchronous video visit, reviews lab work (fasting glucose, HbA1c, liver function tests), and transmits the prescription electronically to any Colorado pharmacy. HealthRX and other telehealth platforms operating in Colorado can prescribe pioglitazone for type 2 diabetes management.

Lab Requirements Before Prescribing

The FDA-approved prescribing information recommends checking ALT levels before initiating pioglitazone and periodically thereafter. Dr. Ralph DeFronzo, a professor of medicine at UT Health San Antonio and lead investigator on multiple thiazolidinedione trials, has stated: "Pioglitazone's hepatotoxicity risk is far lower than troglitazone's was. Routine ALT monitoring is prudent but should not be a barrier to prescribing a drug with proven cardiovascular and metabolic benefits" [5].

Telehealth providers in Colorado can order labs through Quest Diagnostics, Labcorp, or UCHealth draw sites statewide. Results are reviewed asynchronously before the prescription is activated.

How Pioglitazone Compares to Other Diabetes Drug Costs in Colorado

Pioglitazone is among the cheapest diabetes medications available. Here is how it stacks up against other commonly prescribed agents at Colorado retail pharmacies in 2026.

Generic Oral Agents

Metformin 500 mg to 2,000 mg runs $4 to $10 per month. Pioglitazone 15 mg to 45 mg runs $4 to $15. Glipizide and glimepiride both fall in the $4 to $12 range. These four generics represent the lowest tier of diabetes drug spending.

Brand-Name and Specialty Agents

Ozempic (semaglutide 1 mg injection) costs approximately $900 to $1,100 per month without insurance in Colorado. Jardiance (empagliflozin 25 mg) lists at roughly $580 per month before discounts. Even with insurance, SGLT2 inhibitor and GLP-1 receptor agonist copays run $25 to $150 depending on tier placement. Pioglitazone at $4 to $15 out-of-pocket is 50 to 200 times cheaper than injectable GLP-1 agents at list price.

Clinical Context for Cost Decisions

The PROactive trial (N=5,238) demonstrated that pioglitazone reduced the composite of all-cause mortality, non-fatal MI, and stroke by 16% (HR 0.84, 95% CI 0.72 to 0.98) in patients with type 2 diabetes and macrovascular disease over a mean follow-up of 34.5 months [6]. The IRIS trial (N=3,876) showed pioglitazone reduced stroke or MI by 24% in insulin-resistant patients without diabetes [7]. These cardiovascular benefits, combined with the $4 to $15 monthly cost, make pioglitazone a high-value option that the American Diabetes Association Standards of Care includes as a second-line agent when cost is a consideration.

Dr. Silvio Inzucchi, professor of medicine at Yale School of Medicine, has noted: "Pioglitazone remains one of the most underutilized drugs in our diabetes toolkit. Its cost profile and cardiovascular data make it an obvious choice when patients cannot afford newer agents" [8].

Side Effects That Affect Long-Term Cost

Pioglitazone's side-effect profile can influence total cost of care beyond the drug price alone.

Weight Gain and Edema

The PIVENS trial reported mean weight gain of 4.7 kg over 96 weeks with pioglitazone 30 mg versus 0.7 kg with placebo [2]. Peripheral edema occurred in 6.3% of pioglitazone-treated patients. Neither side effect typically requires additional prescription medication, but edema may prompt a dose reduction or diuretic addition ($4 to $8 per month for generic furosemide).

Fracture Risk

A meta-analysis published in CMAJ (2009) found that thiazolidinediones increased fracture risk in women (OR 1.94, 95% CI 1.60 to 2.35), primarily affecting distal extremities [9]. Colorado patients on pioglitazone long-term, particularly postmenopausal women, may need periodic bone density screening (DXA scan, $150 to $350 out-of-pocket or covered under preventive benefits).

Bladder Cancer Signal

The FDA added a bladder cancer warning to pioglitazone's label in 2011 based on a 10-year Kaiser Permanente cohort study that found a modestly elevated risk with cumulative exposure exceeding 2 years [10]. Subsequent large European studies have not confirmed a statistically significant association. The current FDA label recommends avoiding pioglitazone in patients with active bladder cancer and using it with caution in those with a history of the disease.

Colorado-Specific Pharmacy Regulations That Affect Pricing

Mandatory Generic Substitution

Colorado law (C.R.S. § 12-280-120) mandates that pharmacists substitute an FDA-rated AB-equivalent generic for the brand-name drug unless the prescriber explicitly indicates otherwise. This ensures that the vast majority of pioglitazone prescriptions filled in Colorado default to the $4 to $15 generic, not the $60 brand.

Price Transparency Requirements

Colorado's Prescription Drug Affordability Board, established under HB 19-1296 and expanded in subsequent sessions, requires manufacturers to justify price increases exceeding certain thresholds. Pioglitazone's stable generic pricing has kept it off the Board's review docket, but the regulatory framework prevents future price spikes on this and other high-volume generics.

Pharmacy Benefit Manager Regulation

Colorado SB 21-175 prohibits PBMs from setting patient copays higher than the pharmacy's acquisition cost for a drug. For pioglitazone, this means a PBM cannot charge a $15 copay if the pharmacy's wholesale cost is $3. This clawback protection directly benefits Colorado patients filling pioglitazone prescriptions.